• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA ACCEL PLATELET, PLASMA, RBC SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA ACCEL PLATELET, PLASMA, RBC SET Back to Search Results
Model Number 82406
Device Problems Contamination of Device Ingredient or Reagent (2901); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/13/2022
Event Type  malfunction  
Event Description
Customer reported bacterial contamination of a double platelet unit.The bacteria was identified in anaerobic bottles 1 and 2 as diphtheroids.Donor id #: (b)(6) no patient (donor) was connected at the time of the event, therefore, no patient information is available.The platelet collection is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
Investigation: the 20 ml large volume bact samplers increase the volume of inoculum hence better detection of contaminated units with a low bacterial titer.An increase in positive tests is a possibility with enhanced sensitivity.A literature review was conducted for the organisms identified by the customer.Per literature review, diphtheroids are defined as aerobic, non-sporulating, pleomorphic gram-positive bacilli which are usually commensals of the skin and mucous membranes.Since they are usually found as commensals on the skin, they are often considered as mere contaminants when isolated from clinical samples (chandran et al, diphtheroids-important nosocomial pathogens.Journal of clinical and diagnostic research.2016 dec, vol-10(12): dc28-dc31).Per ssi-0228 technical report, the phenomenon of bacterial contamination in blood products, especially platelets, is known to occur.With current technologies, given the nature of microorganisms on human skin and the mechanical act of piercing the skin coupled with the fact that platelets must be incubated at room temperature it is not possible to eliminate this phenomenon from occurring.The devices terumo bct manufactures in lakewood / littleton, co, vietnam, costa rica and harmac to collect, separate and store blood products are terminally sterilized to an sal of < 1.0 x 10-6.Additionally, a sterility assurance system has been designed and employed to ensure this sal will be achieved for every product manufactured.Therefore, it may be concluded bacterial contamination observed in collected blood products from terumo bct devices is most likely due to the inherit hazard of collecting blood as it relates to bacterial contamination.A disposable complaint history search was performed for all the lots and found no other reports for similar issues on these lots.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Root cause: a root cause assessment was performed for the microbial contamination with true positive and indeterminate results.Based on the available information a definitive root cause could not be determined but it is likely due to one or a combination of the possible causes listed below: improper venipuncture technique introduces bacteria at access site resulting in bacterial growth in product bag.Inadequate or no blood diversion performed due to operator error resulting in bacterial contamination of product.Species was endogenous and originated from the donor.Inadequate post-processing laboratory practices such as qc sampling or handling techniques.A root cause assessment was performed for the microbial contamination with false positive results.Based on the customer¿s statement, their qc lab had contaminated the bottles resulting in false positive.
 
Event Description
Customer reported bacterial contamination of a double platelet unit.The bacteria was identified in anaerobic bottles 1 and 2 as diptheroids.Donor id #: (b)(6).No patient (donor) was connected at the time of the event, therefore, no patient information is available.The platelet collection is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA ACCEL PLATELET, PLASMA, RBC SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key14116613
MDR Text Key298787550
Report Number1722028-2022-00117
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583824065
UDI-Public05020583824065
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK190332
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/01/2023
Device Model Number82406
Device Catalogue Number82406
Device Lot Number2112171130
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/23/2022
Initial Date FDA Received04/14/2022
Supplement Dates Manufacturer Received02/27/2023
Supplement Dates FDA Received02/28/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-